The present study demonstrated that lncRNA SPRY4-IT1 promoted breast cancer cell biological activity, whereas NT21MP could inhibit its effect by SDF-1α/CXCR4 pathway, which was partially through SKA2. This evidence concerns the gene SPRY4 and breast carcinoma.